192 related articles for article (PubMed ID: 27681541)
1. Challenges in visceral leishmaniasis control and elimination in the developing countries: A review.
Hailu T; Yimer M; Mulu W; Abera B
J Vector Borne Dis; 2016; 53(3):193-8. PubMed ID: 27681541
[TBL] [Abstract][Full Text] [Related]
2. Will visceral leishmaniasis be eliminated from Nepal? A review of recent (1994-2006) control efforts.
Bhandari GP; Angdembe MR; Rijal S; Boelaert M
Nepal Med Coll J; 2011 Sep; 13(3):220-5. PubMed ID: 22808821
[TBL] [Abstract][Full Text] [Related]
3. Kala-azar elimination in a highly-endemic district of Bihar, India: A success story.
Kumar V; Mandal R; Das S; Kesari S; Dinesh DS; Pandey K; Das VR; Topno RK; Sharma MP; Dasgupta RK; Das P
PLoS Negl Trop Dis; 2020 May; 14(5):e0008254. PubMed ID: 32365060
[TBL] [Abstract][Full Text] [Related]
4. Challenges for malaria elimination in Brazil.
Ferreira MU; Castro MC
Malar J; 2016 May; 15(1):284. PubMed ID: 27206924
[TBL] [Abstract][Full Text] [Related]
5. An overview of visceral leishmaniasis elimination program in India: a picture imperfect.
Gurunath U; Joshi R; Agrawal A; Shah V
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):929-35. PubMed ID: 24930676
[TBL] [Abstract][Full Text] [Related]
6. Can visceral leishmaniasis be eliminated from Asia?
Joshi A; Narain JP; Prasittisuk C; Bhatia R; Hashim G; Jorge A; Banjara M; Kroeger A
J Vector Borne Dis; 2008 Jun; 45(2):105-11. PubMed ID: 18592839
[TBL] [Abstract][Full Text] [Related]
7. A review of new challenges and prospects for malaria elimination in Mutare and Mutasa Districts, Zimbabwe.
Sande S; Zimba M; Chinwada P; Masendu HT; Mberikunshe J; Makuwaza A
Malar J; 2016 Jul; 15(1):360. PubMed ID: 27411705
[TBL] [Abstract][Full Text] [Related]
8. Visceral leishmaniasis: elimination with existing interventions.
Matlashewski G; Arana B; Kroeger A; Battacharya S; Sundar S; Das P; Sinha PK; Rijal S; Mondal D; Zilberstein D; Alvar J
Lancet Infect Dis; 2011 Apr; 11(4):322-5. PubMed ID: 21453873
[TBL] [Abstract][Full Text] [Related]
9. Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence.
Sundar S; Singh OP; Chakravarty J
Expert Rev Anti Infect Ther; 2018 Nov; 16(11):805-812. PubMed ID: 30289007
[TBL] [Abstract][Full Text] [Related]
10. Sustaining visceral leishmaniasis elimination in Bangladesh - Could a policy brief help?
Fitzpatrick A; Al-Kobaisi NSMS; Beitman Maya J; Ren Chung Y; Duhan S; Elbegdorj E; Jain S; Kuhn E; Nastase A; Ahmed BN; Olliaro P
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006081. PubMed ID: 29232385
[TBL] [Abstract][Full Text] [Related]
11. Visceral leishmaniasis control: a public health perspective.
Boelaert M; Criel B; Leeuwenburg J; Van Damme W; Le Ray D; Van der Stuyft P
Trans R Soc Trop Med Hyg; 2000; 94(5):465-71. PubMed ID: 11132368
[TBL] [Abstract][Full Text] [Related]
12. Elimination of visceral leishmaniasis in Nepal: pipe-dreams and possibilities.
Joshi AB; Banjara MR; Pokhrel S; Jimba M; Singhasivanon P; Ashford RW
Kathmandu Univ Med J (KUMJ); 2006; 4(4):488-96. PubMed ID: 18603960
[TBL] [Abstract][Full Text] [Related]
13. Sero-epidemological survey on canine visceral leishmaniasis and the distribution of sandfly vectors in northwestern Turkey: prevention strategies for childhood visceral leishmaniasis.
Dogan N; Ozbel Y; Toz SO; Dinleyici EC; Bor O
J Trop Pediatr; 2006 Jun; 52(3):212-7. PubMed ID: 16287909
[TBL] [Abstract][Full Text] [Related]
14. Control of visceral leishmaniasis in latin america-a systematic review.
Romero GA; Boelaert M
PLoS Negl Trop Dis; 2010 Jan; 4(1):e584. PubMed ID: 20098726
[TBL] [Abstract][Full Text] [Related]
15. Towards elimination of visceral leishmaniasis in the Indian subcontinent-Translating research to practice to public health.
Hirve S; Kroeger A; Matlashewski G; Mondal D; Banjara MR; Das P; Be-Nazir A; Arana B; Olliaro P
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005889. PubMed ID: 29023446
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control.
Bern C; Chowdhury R
Indian J Med Res; 2006 Mar; 123(3):275-88. PubMed ID: 16778310
[TBL] [Abstract][Full Text] [Related]
17. Taking a bite out of vector-transmitted infectious diseases.
Klempner MS; Unnasch TR; Hu LT
N Engl J Med; 2007 Jun; 356(25):2567-9. PubMed ID: 17582066
[No Abstract] [Full Text] [Related]
18. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
Chappuis F; Sundar S; Hailu A; Ghalib H; Rijal S; Peeling RW; Alvar J; Boelaert M
Nat Rev Microbiol; 2007 Nov; 5(11):873-82. PubMed ID: 17938629
[TBL] [Abstract][Full Text] [Related]
19. Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India.
Le Rutte EA; Coffeng LE; Muñoz J; de Vlas SJ
Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):229-235. PubMed ID: 33580952
[TBL] [Abstract][Full Text] [Related]
20. Development of Leishmania vaccines in the era of visceral leishmaniasis elimination.
Engwerda CR; Matlashewski G
Trans R Soc Trop Med Hyg; 2015 Jul; 109(7):423-4. PubMed ID: 26048873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
